Thromboembolism and antithrombotic therapy in peripheral arterial disease.

[1]  V. Fuster,et al.  Role of platelet activation and fibrin formation in thrombogenesis. , 1986, Journal of the American College of Cardiology.

[2]  A. Bass,et al.  Percutaneous transluminal angioplasty. A suggested method for analysis of clinical, arteriographic, and hemodynamic factors affecting the results of treatment. , 1986, Journal of vascular surgery.

[3]  M. Geisinger,et al.  Peripheral artery and bypass graft thrombolysis with recombinant human tissue-type plasminogen activator. , 1986, Journal of vascular surgery.

[4]  R. Verhaeghe,et al.  PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO-CENTRE TRIAL OF KETANSERIN IN INTERMITTENT CLAUDICATION , 1985, The Lancet.

[5]  D. Collen.  Human tissue-type plasminogen activator: from the laboratory to the bedside. , 1985, Circulation.

[6]  G. Deichsel,et al.  DRUG-INDUCED INHIBITION OF PLATELET FUNCTION DELAYS PROGRESSION OF PERIPHERAL OCCLUSIVE ARTERIAL DISEASE A Prospective Double-Blind Arteriographically Controlled Trial , 1985, The Lancet.

[7]  A. Bollinger,et al.  Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy. , 1985, VASA. Zeitschrift fur Gefasskrankheiten.

[8]  C. Diehm,et al.  [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration]. , 2008, Deutsche medizinische Wochenschrift.

[9]  J. Crée,et al.  PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATION , 1984, The Lancet.

[10]  K. Balzer,et al.  Buflomedil in Arterial Occlusive Disease: Results of a Controlled Multicenter Study , 1984, Angiology.

[11]  M. Verstraete,et al.  Clinical ineffectiveness of intra-arterial or intra-venous infusions of epoprostenol in patients with peripheral obliterative disease, Stage III to IV , 1984 .

[12]  C. Francis,et al.  An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis. , 1984, Progress in hemostasis and thrombosis.

[13]  D. Brewster,et al.  Factors affecting patency of femoropopliteal bypass grafts. , 1983, Surgery, gynecology & obstetrics.

[14]  C. Mccollum,et al.  Does 111indium‐platelet deposition predict patency in prosthetic arterial grafts? , 1983, The British journal of surgery.

[15]  J. Pollock,et al.  EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASE A Double-blind Trial , 1983, The Lancet.

[16]  D. Taberner.  Iron deficiency and stanozol therapy. , 1983, Lancet.

[17]  H. Hess,et al.  Local low-dose thrombolytic therapy of peripheral arterial occlusions. , 1982, The New England journal of medicine.

[18]  D. C. Brewster,et al.  Aortofemoral graft for multilevel occlusive disease. Predictors of success and need for distal bypass. , 1982, Archives of surgery.

[19]  R. Ritz,et al.  Sequential Treatment of Arterial Occlusions with Porcine Plasmin and Low Dose Streptokinase , 1982, Thrombosis and Haemostasis.

[20]  D. Strandness,et al.  Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. , 1982, American heart journal.

[21]  C. Forbes,et al.  Double-Blind Controlled Clinical Trial of Ancrod for Ischemic Rest Pain of the Leg , 1982, Angiology.

[22]  Yao Js,et al.  Comparison of long-term results after balloon dilatation to the results of arterial reconstructive surgery. , 1982 .

[23]  A V Uchôa,et al.  [Percutaneous transluminal angioplasty]. , 1982, AMB : revista da Associacao Medica Brasileira.

[24]  B. Katzen,et al.  Low dose streptokinase in the treatment of arterial occlusions. , 1981, AJR. American journal of roentgenology.

[25]  W. Daenen,et al.  Aortofemoral grafting: factors influencing late results. , 1980, Surgery.

[26]  A. Raftery,et al.  INTRA-ARTERIAL HYALURONIDASE IN SEVERE PERIPHERAL ARTERIAL DISEASE , 1980, The Lancet.

[27]  T. Katsumura,et al.  Therapeutic effects of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases , 1980 .

[28]  J. D. Coffman.  Vasodilator drugs for peripheral vascular disease. , 2010, The New England journal of medicine.

[29]  B. Kaye.  Vasodilator drugs in peripheral vascular disease , 1979 .

[30]  E. Ring,et al.  Transluminal angioplasty of the iliac, femoral, and popliteal arteries. , 1979, Radiology.

[31]  A. Szczeklik,et al.  SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLIN , 1979, The Lancet.

[32]  B. Jacobsson,et al.  Treatment and sequelae of angiographic complications in children. , 1979, Journal of pediatric surgery.

[33]  J. D. Coffman.  Drug therapy: vasodilator drugs in peripheral vascular disease. , 1979, The New England journal of medicine.

[34]  C. Shuman,et al.  Long-term results of 474 arterial reconstructions for severely ischemic limbs: a fourteen year follow-up. , 1979, Surgery.

[35]  J. Mannick,et al.  Effect of arterial reconstruction on limb salvage: a ten-year appraisal. , 1978, Archives of surgery.

[36]  R. Kraft,et al.  Chronic upper extremity arterial insufficiency. Etiology, manifestations, and operative management. , 1978, Archives of surgery.

[37]  N. Lassen,et al.  Intra-arterial infusion of prostaglandin E1 in normal subjects and patients with peripheral arterial disease. , 1976, Scandinavian journal of clinical and laboratory investigation.

[38]  W. Moore,et al.  The natural history of bilateral aortofemoral bypass grafts for ischemia of the lower extremities. , 1975, Archives of surgery.

[39]  N. Lassen,et al.  Induced hypertension as a therapy in Buerger's disease (thromboangitis obliterans). , 1975, VASA. Zeitschrift fur Gefasskrankheiten.

[40]  R. Green,et al.  Arterial embolectomy before and after the Fogarty catheter. , 1975, Surgery.

[41]  A. Grüntzig,et al.  [Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author's transl)]. , 1974, Deutsche medizinische Wochenschrift.

[42]  I. Leusen,et al.  ŒSTROGEN SYNTHESIS BY HUMAN BREAST CARCINOMAS , 1974 .

[43]  J. Rösch,et al.  Selective clot lysis with low-dose streptokinase. , 1974, Radiology.

[44]  J. Baak,et al.  Letter: The thymus and sudden unexplained infant death. , 1974, Lancet.

[45]  L. Glaus,et al.  [Chronic occlusion of arteries in the extremities and long-term anticoagulant therapy. Studies on 140 men with several angiographies]. , 1974, VASA. Zeitschrift fur Gefasskrankheiten.

[46]  W. van Aken,et al.  Spontaneous aggregation of blood platelets as a cause of idiopothic thrombosis and recurrent painful toes and fingers. , 1971, Lancet.

[47]  M. Verstraete,et al.  The effect of streptokinase infusion on chronic arterial occlusions and stenoses. , 1971, Annals of internal medicine.

[48]  A. Amery,et al.  Outcome of Recent Thromboembolic Occlusions of Limb Arteries Treated with Streptokinase , 1970, British medical journal.

[49]  N. Lassen,et al.  Conservative treatment of gangrene using mineralocorticoid-induced moderate hypertension. , 1968, Lancet.

[50]  N. Lassen,et al.  Effect of daily muscular exercise in patients with intermittent claudication. , 1966, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[51]  C. Tillgren.  Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy. , 2009, Acta medica Scandinavica.

[52]  M. P. Judkins,et al.  Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application , 1964, Circulation.

[53]  E. Pask,et al.  TREATMENT OF ACUTE LEUKAEMIA. , 1964, The Lancet.

[54]  R. Pinsent,et al.  A DESIGN FOR GENERAL PRACTICE. I. REINFORCEMENT FOR THE FAMILY DOCTOR. , 1963, Lancet.